Omzo vs Wellorithm: Semaglutide Care, Pricing & Access
Quick verdict: Omzo and Wellorithm both offer clinician-guided GLP-1 options, but Omzo centers on personalized compounded programs with clinician review and branded prescriptions by referral, while Wellorithm emphasizes broad 50-state virtual access and a lower listed entry price. This makes Omzo a fit for patients who want clinician-reviewed compounded plans and the option of prescriptions for branded meds, and Wellorithm a stronger option for nationwide virtual access and lower starting pricing.
See Omzo clinician-guided plans
Head-to-head: Omzo vs Wellorithm overview
The comparison Omzo vs Wellorithm comes down to four distinctive differences supported by the source: starting price and pricing transparency, clinician coverage and state availability, medication type and dispensing model, and shipping and included services. Each provider offers compounded semaglutide and tirzepatide options, but the details and limitations differ.
1) Starting price and pricing transparency
Omzo lists semaglutide starting at $179 and tirzepatide starting at $279 as part of its clinician-guided, compounded medication program. Wellorithm lists options starting at $147 for compounded semaglutide and $249 for tirzepatide in its marketing copy, but its FAQ notes that Wellorithm does not publish full pricing on its website and that you receive a personalized quote after the intake quiz. Preserve these qualifiers when weighing cost expectations.
Check Wellorithm eligibility and quote
2) Clinician coverage and state availability
Omzo connects users with licensed U.S. providers through third party clinician networks and notes that clinical services are provided by those networks; eligibility, state coverage, and renewal terms may change. Wellorithm advertises licensed clinicians in all 50 states, positioning itself as a solution for patients in states with limited GLP-1 telehealth options. If state coverage is critical, the source supports Wellorithm as having broader nationwide clinician coverage.
3) Medication options and dispensing model
Both platforms offer compounded semaglutide and tirzepatide. Omzo’s primary program is a Compounded Medication Program using state-licensed sterile compounding pharmacies and explicitly notes those compounded drugs are not FDA-approved. Omzo also states that providers may write prescriptions for branded FDA-approved medications but that Omzo does not sell, dispense, or ship branded meds; patients must fill branded prescriptions at their chosen pharmacy. Wellorithm provides compounded medications shipped to the home after a virtual consultation and notes compounded medications are not FDA-approved. Wellorithm’s FAQ highlights that its medications are compounded at licensed pharmacies and use the same active ingredients as branded versions, but it states that only compounded medications are offered by the platform.
4) Shipping, delivery and included services
Omzo markets fast, discreet delivery and notes FSA and HSA eligibility. Wellorithm promotes fast, free shipping and a fully virtual consultation model with medication shipped to the home. Wellorithm also emphasizes no membership or hidden fees in its marketing copy, though the FAQ indicates actual cost details come after the intake quiz.
Comparison table
| Criteria | Omzo | Wellorithm |
|---|---|---|
| Starting price | $179 for semaglutide; $279 for tirzepatide | Listed marketing start at $147 for semaglutide; quotes provided after intake |
| Clinician coverage | Licensed U.S. providers via third party networks; state availability may vary | Licensed clinicians in all 50 states |
| Medication type | Compounded semaglutide and tirzepatide; providers may prescribe branded meds but Omzo does not dispense branded meds | Compounded semaglutide and tirzepatide shipped to home; compounded only |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
| Delivery & fees | Fast, discreet delivery; FSA and HSA eligible | Fast, free shipping; no membership or hidden fees claimed in marketing |
How the providers handle clinical decisions and prescriptions
Omzo states that licensed clinicians determine eligibility and make the final determination to prescribe any medication, and that clinical services are provided by third party networks. Omzo warns that its assessment does not create a doctor-patient relationship on the Omzo website itself. Wellorithm describes a 2-minute quiz followed by a licensed clinician review; treatment is available only when a clinician deems it medically appropriate. Both providers emphasize clinician review and the need for medical appropriateness.
Explore Omzo medication options
Evidence and limitations to note
Both sites explicitly note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Omzo repeatedly cautions that results vary and eligibility is not guaranteed. Wellorithm includes marketing examples of weight-loss cases but the source states that treatment is available only when a licensed clinician finds it appropriate and that pricing details are provided after intake.
Start Wellorithm quiz and get a quote
Choose Omzo if…
You want clinician-guided plans reviewed by licensed U.S. providers with a primary compounded medication program and the explicit option that providers may write prescriptions for branded FDA-approved medications, and you accept that compounded drugs are not FDA-approved and that state availability, pricing, and renewal terms may change.
Choose Wellorithm if…
You need a telehealth option with licensed clinicians in all 50 states, prefer a fully virtual consultation model with medication shipped to your home, and want a provider that advertises lower listed entry pricing and free shipping while understanding final costs are provided after the intake quiz and compounded medications are not FDA-approved.